Sanofi and ScionxBio partner on mRNA therapies

​

Sanofi has signed a global licensing and strategic collaboration agreement with UK-based biotechnology firm ScionxBio to develop long-acting mRNA therapies using the TERA platform.

The post Sanofi and ScionxBio partner on mRNA therapies appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.